Yismeilin R. Feliz‐Mosquea

Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy

Yismeilin R. Feliz‐Mosquea, Ashley Christensen, Adam S. Wilson et al. · Breast Cancer Research and Treatment · 2018 · 55 citations

Medicine, Oncology, Pharmacology +12

<i>Ganoderma lucidum</i> Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression

Ivette J. Suárez-Arroyo, Tiffany J. Rios-Fuller, Yismeilin R. Feliz‐Mosquea et al. · Journal of Cancer · 2016 · 32 citations · Full text

Medicine, Oncology, Pharmacology +15

The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.

Ivette J. Suárez-Arroyo, Yismeilin R. Feliz‐Mosquea, Juliana Pérez-Laspiur et al. · PubMed · 2016 · 27 citations

Medicine, Molecular Biology, Oncology +17

Diet impacts triple‐negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin‐mediated cardiac dysfunction

Manuel U. Ramirez, Kenysha Y.J. Clear, Zipporah Cornelius et al. · Physiological Reports · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17